An organism's metabolic profile changes every day and even every hour. The development of advanced high resolution non destructive techniques, such as, nuclear magnetic ressonance (NMR) allowed the research on how and when this profile changes and, more important, how they can be related with diseases by indentifing which molecules are associated for each symptom. Thus NMR metabolomics started to show potential for becaming a diagnosis tool. With NMR metabolomics and chemotmetrics we observed that it is possible to have evidences if someone is healthy or if is a schizophrenic person.
Introduction
The metabolome of an organism is a set of metabolites which are tiny molecules that play an important role in the cell activities or may be products of some protein synthesis. The metabolome changes its composition along the day and shows different profiles whether an organism is healthy or not. With the development of advanced techniques (e.g. NMR) that provides highresolution non-destructive analyses, it is now possible to investigate how metabolome changes. 1
Results and Discussion
Our research is based on NMR analyses of blood serum samples from healthy people (control) and from those who demonstrated schizophrenia (SCZ) symptoms. The spectra were processed with a spreadsheet software and then analyzed with chemometrics techniques such as PCA and PLS-DA. The blood samples were collected using vacutainers with anticoagulant, between 8-10 h AM, centrifuged, and the supernatant, which is the blood serum, was kept at -80 °C by the maximum period of 2 weeks. In a micro tube, 500 μL of deuterium oxide was mixed with the same amount of serum sample, and placed into a 5 mm NMR tube. Each sample was analyzed in triplicate, using a Bruker Avance III 600 MHz spectrometer, and analyses were done at 25 °C. The differences between the spectra (Figure 1) of healthy, which was used as control group, and SCZ people is observed in two NMR spectral regions, from 1.00 -4.40 ppm and from 7.50 -8.00 ppm. These regions were used for chemometrics analyses. The separation of the groups may be related to abnormalities of some neurotransmitters in SCZ patients, like dopamine and glutamate. 2
Conclusions
PCA and PLS-DA analyses showed that the two groups can be differentiated with the information provided by the 1 H NMR spectra, suggesting that it can be a reliable diagnosis essay or, at least, a powerful aid to enhance the traditional method. The method should be repeated with a greater number of samples to minimize the effects of artifact signals, outliers and some other experimental errors.
